178 related articles for article (PubMed ID: 37210707)
1. Veterans Health Administration: Implementation of pharmacogenomic clinical decision support with statin medications and the SLCO1B1 gene as an exemplar.
Tomcsanyi KM; Tran KA; Bates J; Cunningham FE; Silverman R; Norris AK; Moore VR; Voora D
Am J Health Syst Pharm; 2023 Aug; 80(16):1082-1089. PubMed ID: 37210707
[TBL] [Abstract][Full Text] [Related]
2. Progression of precision statin prescribing for reduction of statin-associated muscle symptoms.
Petry NJ; Baye JF; Frear S; Jacobsen K; Massmann A; Schultz A; Heukelom JV; Christensen K
Pharmacogenomics; 2022 Jul; 23(10):585-596. PubMed ID: 35775396
[No Abstract] [Full Text] [Related]
3. A Cost-Consequence Analysis of Preemptive
Brunette CA; Dong OM; Vassy JL; Danowski ME; Alexander N; Antwi AA; Christensen KD
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834475
[TBL] [Abstract][Full Text] [Related]
4. Effect of Pharmacogenetic Testing for Statin Myopathy Risk vs Usual Care on Blood Cholesterol: A Randomized Clinical Trial.
Vassy JL; Gaziano JM; Green RC; Ferguson RE; Advani S; Miller SJ; Chun S; Hage AK; Seo SJ; Majahalme N; MacMullen L; Zimolzak AJ; Brunette CA
JAMA Netw Open; 2020 Dec; 3(12):e2027092. PubMed ID: 33270123
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal Symptoms.
Cooper-DeHoff RM; Niemi M; Ramsey LB; Luzum JA; Tarkiainen EK; Straka RJ; Gong L; Tuteja S; Wilke RA; Wadelius M; Larson EA; Roden DM; Klein TE; Yee SW; Krauss RM; Turner RM; Palaniappan L; Gaedigk A; Giacomini KM; Caudle KE; Voora D
Clin Pharmacol Ther; 2022 May; 111(5):1007-1021. PubMed ID: 35152405
[TBL] [Abstract][Full Text] [Related]
6. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
[No Abstract] [Full Text] [Related]
7. The Integrating Pharmacogenetics in Clinical Care (I-PICC) Study: Protocol for a point-of-care randomized controlled trial of statin pharmacogenetics in primary care.
Vassy JL; Brunette CA; Majahalme N; Advani S; MacMullen L; Hau C; Zimolzak AJ; Miller SJ
Contemp Clin Trials; 2018 Dec; 75():40-50. PubMed ID: 30367991
[TBL] [Abstract][Full Text] [Related]
8. Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users.
Chanfreau-Coffinier C; Hull LE; Lynch JA; DuVall SL; Damrauer SM; Cunningham FE; Voight BF; Matheny ME; Oslin DW; Icardi MS; Tuteja S
JAMA Netw Open; 2019 Jun; 2(6):e195345. PubMed ID: 31173123
[TBL] [Abstract][Full Text] [Related]
9. Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program.
Dong OM; Bates J; Chanfreau-Coffinier C; Naglich M; Kelley MJ; Meyer LJ; Icardi M; Vassy JL; Sriram P; Heise CW; Rivas S; Ribeiro M; Jacobitz R; Rozelle S; Chapman JG; Voora D
Pharmacogenomics; 2021 Feb; 22(3):137-144. PubMed ID: 33403869
[TBL] [Abstract][Full Text] [Related]
10. Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.
Brunham LR; Baker S; Mammen A; Mancini GBJ; Rosenson RS
Cardiovasc Res; 2018 Jul; 114(8):1073-1081. PubMed ID: 29878063
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES Trial.
Murphy WA; Lin N; Damask A; Schwartz GG; Steg PG; Szarek M; Banerjee P; Fazio S; Manvelian G; Pordy R; Shuldiner AR; Paulding C
Circ Genom Precis Med; 2022 Jun; 15(3):e003503. PubMed ID: 35543701
[TBL] [Abstract][Full Text] [Related]
12.
Massmann A; Van Heukelom J; Green RC; Hajek C; Hickingbotham MR; Larson EA; Lu CY; Wu AC; Zoltick ES; Christensen KD; Schultz A
Pharmacogenomics; 2023 May; 24(7):399-409. PubMed ID: 37232094
[No Abstract] [Full Text] [Related]
13. Prescriber Adoption of SLCO1B1 Genotype-Guided Simvastatin Clinical Decision Support in a Clinical Pharmacogenetics Program.
Obeng AO; Scott SA; Kaszemacher T; Ellis SB; Mejia A; Gomez A; Nadukuru R; Abul-Husn NS; Vega A; Waite E; Gottesman O; Cho J; Bottinger EP
Clin Pharmacol Ther; 2023 Feb; 113(2):321-327. PubMed ID: 36372942
[TBL] [Abstract][Full Text] [Related]
14. A gene risk score using missense variants in SLCO1B1 is associated with earlier onset statin intolerance.
Bigossi M; Maroteau C; Dawed AY; Taylor A; Srinivasan S; Melhem AL; Pearson ER; Pola R; Palmer CNA; Siddiqui MK
Eur Heart J Cardiovasc Pharmacother; 2023 Sep; 9(6):536-545. PubMed ID: 37253618
[TBL] [Abstract][Full Text] [Related]
15. Effects of Delivering SLCO1B1 Pharmacogenetic Information in Randomized Trial and Observational Settings.
Peyser B; Perry EP; Singh K; Gill RD; Mehan MR; Haga SB; Musty MD; Milazzo NA; Savard D; Li YJ; Trujilio G; Voora D
Circ Genom Precis Med; 2018 Sep; 11(9):e002228. PubMed ID: 30354330
[TBL] [Abstract][Full Text] [Related]
16. Multi-gene Pharmacogenomic Testing That Includes Decision-Support Tools to Guide Medication Selection for Major Depression: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2021; 21(13):1-214. PubMed ID: 34484487
[TBL] [Abstract][Full Text] [Related]
17. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
[TBL] [Abstract][Full Text] [Related]
18. Integrating pharmacogenomics into electronic health records with clinical decision support.
Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics of medications given via nonconventional administration routes: a scoping review.
Socco S; Wake DT; Lee JC; Dunnenberger HM
Pharmacogenomics; 2022 Nov; 23(17):933-948. PubMed ID: 36326000
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
